Merck Pill: Approved for Urgent Use in the USA


THE Food and Drug Administrationν (FDA) of the USA today approved its use Merck antiviral pill for COVID-19, following the approval of a similar Pfizer pill one day earlier.

Merck’s molnupiravir formulation, developed jointly with Ridgeback Biotherapeutics, has been shown to reduce hospitalizations and deaths by approximately 30% in clinical trials performed with people at high risk at the onset of the disease.

The body approved the use of the drug that taken orally for the treatment of mild to moderate COVID in adults at risk of serious disease, and by those who do not have access to treatment alternatives for COVID-19 or are not clinically suitable for them.

The US government has a contract to purchase up to five million doses of the drug for $ 700 per dose. The drug is not approved for use in patients under 18 years of age because molnopiravir can affect bone and cartilage growth, the FDA said in a statement.

Source: ΑΠΕ – ΜΠΕ  

Leave A Reply

Your email address will not be published.